Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vatalanib in Multiple Myeloma
NCT00165347Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Dec 2003
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vatalanib in multiple myeloma (MM), sponsored by Dana-Farber Cancer Institute. Started Dec 2003; status: completed.
02
Drugs
vatalanib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00165347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00165347.